This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konradsen, H. B. Articles by Kaltoft, M. S. Search for Related Content PubMed PubMed Citation Articles by Konradsen, H. B. Articles by Kaltoft, M. S.

Invasive Pneumococcal Infections in Denmark from 1995 to 1999: Epidemiology, Serotypes, and Resistance

Streptococcus Unit, Department of Respiratory Infections, Meningitis and STIs, Division of Microbiology, Statens Serum Institut, DK-2300 Copenhagen, Denmark

Received 11 June 2001/ Returned for modification 7 September 2001/ Accepted 15 November 2001

Danish nationwide surveillance data on invasive pneumococcal disease from the 5-year period from 1995 to 1999, including 5,452 isolates, are presented and described. Annual overall incidence rates, serotype distribution, and antimicrobial susceptibility patterns of the isolates were monitored. Major changes in the total annual incidence rate from 27/100,000 in 1996 to 17/100,000 in 1999 and a significant change in the proportion of invasive isolates belonging to types 1 and 12F were observed. The serotype coverage rate by the 23-valent polysaccharide vaccine among the elderly was 92.9%, and the serotype coverage rate by the 7-, 9-, and 11-valent pneumococcal conjugate vaccines among children less than 2 years old were 71.7, 75.2, and 81.4%, respectively. Invasive isolates with reduced susceptibility to penicillin or erythromycin increased from 1995 to 1999, with a high proportion of the penicillin-nonsusceptible invasive isolates originating from people 60 years old or older (57.0%). These observations underline the importance of adequate surveillance systems of invasive pneumococcal disease to introduce and maintain national vaccine strategies and adequate antibiotic policy.

This article has been cited by other articles:

• Kirkham, L.-A. S., Jefferies, J. M. C., Kerr, A. R., Jing, Y., Clarke, S. C., Smith, A., Mitchell, T. J. (2006). Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin. J. Clin. Microbiol. 44: 151-159 [Abstract] [Full Text]  
• Westman, E., Lundin, S., Hermansson, A., Melhus, A. (2004). {beta}-Lactamase-Producing Nontypeable Haemophilus influenzae Fails To Protect Streptococcus pneumoniae from Amoxicillin during Experimental Acute Otitis Media. Antimicrob. Agents Chemother. 48: 3536-3542 [Abstract] [Full Text]  
• Decousser, J.-W., Pina, P., Viguier, F., Picot, F., Courvalin, P., Allouch, P. (2004). Invasive Streptococcus pneumoniae in France: Antimicrobial Resistance, Serotype, and Molecular Epidemiology Findings from a Monthly National Study in 2000 to 2002. Antimicrob. Agents Chemother. 48: 3636-3639 [Abstract] [Full Text]  
• Brueggemann, A. B., Spratt, B. G. (2003). Geographic Distribution and Clonal Diversity of Streptococcus pneumoniae Serotype 1 Isolates. J. Clin. Microbiol. 41: 4966-4970 [Abstract] [Full Text]  
• Fedson, D. S., Konradsen, H. B., Nokleby, H., Whitney, C. G., the Active Bacterial Core Surveillance Team, (2003). The Conjugate Vaccine and Invasive Pneumococcal Disease. NEJM 349: 714-716 [Full Text]  
• Decousser, J.-W., Pina, P., Picot, F., Delalande, C., Pangon, B., Courvalin, P., Allouch, P., the ColBVH study group, (2003). Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother 51: 1213-1222 [Abstract] [Full Text]